Literature DB >> 30201827

Impact of antibiotics for children presenting to general practice with cough on adverse outcomes: secondary analysis from a multicentre prospective cohort study.

Niamh M Redmond1, Sophie Turnbull2, Beth Stuart3, Hannah V Thornton2, Hannah Christensen4, Peter S Blair5, Brendan C Delaney6, Matthew Thompson7, Tim J Peters8, Alastair D Hay2, Paul Little3.   

Abstract

BACKGROUND: Clinicians commonly prescribe antibiotics to prevent major adverse outcomes in children presenting in primary care with cough and respiratory symptoms, despite limited meaningful evidence of impact on these outcomes. AIM: To estimate the effect of children's antibiotic prescribing on adverse outcomes within 30 days of initial consultation. DESIGN AND
SETTING: Secondary analysis of 8320 children in a multicentre prospective cohort study, aged 3 months to <16 years, presenting in primary care across England with acute cough and other respiratory symptoms.
METHOD: Baseline clinical characteristics and antibiotic prescribing data were collected, and generalised linear models were used to estimate the effect of antibiotic prescribing on adverse outcomes within 30 days (subsequent hospitalisations and reconsultation for deterioration), controlling for clustering and clinicians' propensity to prescribe antibiotics.
RESULTS: Sixty-five (0.8%) children were hospitalised and 350 (4%) reconsulted for deterioration. Clinicians prescribed immediate and delayed antibiotics to 2313 (28%) and 771 (9%), respectively. Compared with no antibiotics, there was no clear evidence that antibiotics reduced hospitalisations (immediate antibiotic risk ratio [RR] 0.83, 95% confidence interval [CI] = 0.47 to 1.45; delayed RR 0.70, 95% CI = 0.26 to 1.90, overall P = 0.44). There was evidence that delayed (rather than immediate) antibiotics reduced reconsultations for deterioration (immediate RR 0.82, 95% CI = 0.65 to 1.07; delayed RR 0.55, 95% CI = 0.34 to 0.88, overall P = 0.024).
CONCLUSION: Most children presenting with acute cough and respiratory symptoms in primary care are not at risk of hospitalisation, and antibiotics may not reduce the risk. If an antibiotic is considered, a delayed antibiotic prescription may be preferable as it is likely to reduce reconsultation for deterioration. © British Journal of General Practice 2018.

Entities:  

Keywords:  adverse outcomes; antibiotics; children; cohort studies; primary care; respiratory tract infections

Mesh:

Substances:

Year:  2018        PMID: 30201827      PMCID: PMC6145994          DOI: 10.3399/bjgp18X698873

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


INTRODUCTION

Children presenting with cough and other symptoms of respiratory tract infection (RTI) are the most frequent attenders to general practice internationally, are almost all managed in primary care, and the majority still receive antibiotics.1–3 A very small percentage of children are hospitalised for serious bacterial illnesses or complications.4,5 However, GPs are risk averse and report prescribing antibiotics at the point of presentation to this patient group ‘just in case’6,7 and in fear of a poor outcome.6–9 This uncertainty is fuelled by the very limited experimental or observational evidence available regarding the impact of different antibiotic prescribing strategies on major adverse outcomes among children. Available systematic reviews suggest that antibiotics have limited efficacy in treating a large proportion of upper RTIs10–13 but the reviews are underpowered to assess complications and there is little evidence for bronchitis, in particular. Although there is some evidence for adults,14–19 there is almost no meaningful evidence in children regarding complications if antibiotics are withheld for respiratory infections. The major problem with continuing to prescribe for respiratory infections in children is that primary care antibiotic use is a major driver of antibiotic resistance internationally.20 Two large prospective cohort studies of adults with RTI symptoms demonstrated that either immediate or delayed antibiotic prescriptions can modify health outcomes.18,19 The authors were aware of no comparable data in children. This paper used data from a large cohort study to establish whether an immediate or delayed antibiotic prescription given to children with acute cough and RTI in primary care modifies risk of subsequent hospitalisation or reconsultation with deterioration.

METHOD

A large, four-centre (England, UK) prospective cohort study was conducted that recruited children aged 3 months to <16 years presenting to primary care with acute cough and RTI between July 2011 and May 2013. The results from the primary aim of the study have been published.5 Here are presented findings from a secondary analysis.

How this fits in

Antibiotic prescribing to children in primary care is one of the key areas of inappropriate prescribing. This is mainly due to the lack of evidence for, and uncertainty regarding, which children are at risk of poor outcome. This study investigated whether antibiotic prescribing had an impact on two adverse health outcomes for children: hospitalisation for respiratory tract infections and reconsultation for deteriorating symptoms. The study shows that there is little evidence to justify the use of antibiotics for reducing hospitalisation, which occurred very rarely, and supports previous research in adults that a delayed antibiotic prescribing strategy is likely to reduce reconsultation for deterioration. The protocol has been described elsewhere.21 In summary, eligible children presenting to primary care were recruited by prescribing ‘clinicians’ (GPs and prescribing practice nurses) across four centres if they presented with acute cough as the most prominent symptom, combined with other symptoms or signs suggestive of RTI. Clinicians who self-reported prescribing antibiotics in ≤30% to children with RTIs were invited to participate. Following informed consent, clinicians completed a structured case report form (Appendix 1) that included sociodemographics, parent-reported symptoms, clinician-assessed signs, diagnosis, and whether an immediate or delayed antibiotic was prescribed (including number of days delayed) at the time of the consultation. The main outcomes, hospitalisation for any RTI in the 30 days following recruitment and reconsultation for deterioration (a proxy marker for reconsultation for the same episode of RTI illness with evidence of worsening illness, shown to be reliably assessed),22 were collected via a detailed review of the child’s medical record. History of chronic conditions was also recorded. Medical record reviews were generally conducted 3 months post-recruitment for each child, to allow for adequate feedback to occur. On some occasions this was slightly longer than 3 months, and in all cases the period of time was sufficient to allow both reconsultations and complications to occur. Double, independent medical record review was undertaken in a random set of 1% of participants to estimate inter-reviewer error.

Data preparation

Children referred for acute hospitalisation at the consultation were excluded from the analysis, as clinicians’ prescribing behaviour was expected to differ for children whom they had decided to refer to hospital on the same day as the consultation, compared with those they did not. Common clinical cut-offs were used for continuous data where possible (high temperature >37.8°C)23 and were age-related if appropriate (age-specific heart and respiratory rates and blood pressure).24 UK guidelines for low oxygen saturation level (≤95%) were used.25 Given the large number of variables, continuous variables were dichotomised using 25th or 75th percentile cut-offs as appropriate. For carer-reported symptom severity (mild, moderate, or severe) in the 24 hours prior to consultation, dichotomy for each variable was split, depending on the overall prevalence, to either ‘severe’ if more than 5% of the whole cohort fell into this category or ‘moderate and severe’ if the proportion was smaller. This pragmatic cut-off was chosen prior to analysis to avoid variables with very low prevalence. Capillary refill time (CRT) was coded as normal (≤2 seconds) or long (≥3 seconds).26,27 Multiple deprivation score was based on the family postcode using the UK Indices of Multiple Deprivation 2007.28

Covariates

Variables measured at the baseline consultation (symptoms, signs, demographics) were identified as possible confounders/covariates. These variables were considered during the analysis of secondary outcomes (Appendix 2).

Statistical analysis

All data were analysed using STATA (version 13.1). The κ statistic to assess inter-rater reliability of the two main outcomes was calculated. Generalised linear modelling with a log link to produce risk ratios (RR) was used, accounting for clustering by clinician and controlling for potential covariates associated with the prescription strategy and the two outcomes. Two models were generated: in the first, variables were selected using backward stepwise selection with variables retained if the P-value <0.05. In the second model, analyses were conducted post-hoc, where a stratified propensity score was created, which allowed for more rigorous control of potential confounding by indication.29,30

RESULTS

Ascertainment and baseline characteristics

Between July 2011 and May 2013, 518 clinicians recruited children from 247 primary care practices across England. A total of 8613 children were recruited, and, of these, 219 (3%) children were excluded: 181 did not meet eligibility, 32 children did not have baseline data, and six children were withdrawn. Seventy-four children referred for acute hospital admission on the day of recruitment were excluded from the analysis, leaving a total of 8320 children. Antibiotic prescription data from the baseline consultation were available for 100% of these children and all analyses used this final sample of 8320. Figure 1 details the flow of participants through the study. The outcome of hospitalisation was obtained for 8320 (100%) children, and reconsultation for deterioration was obtained for 98% (n = 8136/8320).
Figure 1.

Inter-reviewer agreement analysis for medical record data collection was assessed. For hospitalisation this was 90% (κ 0.80) and 84% for reconsultation within r the same episode of illness (κ 0.67). Missing data for candidate predictors were infrequent (<2%) with the exception of oxygen saturation (50% missing values) due to lack of available paediatric monitors. Clinicians prescribed antibiotics for 3084/8320 children (37%), with 2313 (28%) children prescribed immediate and 771 (9%) delayed antibiotics. The range of days the prescription was delayed for was between 0–10, median 2 (interquartile range [IQR] 2–3). Of the 8320 children included in the analysis, 65 (0.8%) were hospitalised for an RTI in the 30 days following recruitment. Median time to hospitalisation was 4 days (IQR 1–15) with 5% hospitalised on the day of recruitment (day 0), 52% on days 1–7, 17% on days 8–14, and 26% on days 15–30. Of the 65 children hospitalised, 25 (38.5%) had been prescribed an antibiotic. The most common RTI discharge diagnoses (Table 1) were bronchiolitis (20%), lower RTI (14%), and upper RTI (12%); other diagnoses included viral wheeze, exacerbation of asthma, tonsillitis, croup, unspecified viral illness, chest infection, bronchiolitis and bronchitis, viral pneumonitis, pyrexia, and febrile convulsions.
Table 1.

Hospital discharge diagnoses in the 30 days post-recruitment for children who were and were not prescribed an antibiotic at the baseline general practice consultation

Hospital diagnosisNumber of children
ImmediateDelayedNot prescribedTotal
Bronchiolitis121013
LRTI6039
URTI0358
Exacerbation of asthma2046
Tonsillitis3036
Viral wheeze2046
Croup1135
Unspecified viral illness1023
Chest infection1012
Bronchiolitis and bronchitis0011
LRTI/viral pneumonitis1001
Pyrexia1001
URTI and febrile convulsions0011
No record0033
Total1964065

LRTI = lower respiratory tract infection. URTI = upper respiratory tract infection.

Hospital discharge diagnoses in the 30 days post-recruitment for children who were and were not prescribed an antibiotic at the baseline general practice consultation LRTI = lower respiratory tract infection. URTI = upper respiratory tract infection. Just over one-fifth (22.5%; 1830/8136) of children reconsulted for any RTI symptoms in the 30 days after consultation, 14% (1163/8136) reconsulted for the same episode of RTI illness, and 4% (350/8136) reconsulted for the same RTI with evidence in their medical records of deteriorating symptoms. Appendix 3 shows the clinical history, sociodemographics, parent/carer-reported symptoms, clinical signs observed by the clinician, and adverse health outcomes (in the 30 days post-baseline) for the children with different antibiotic strategies at the baseline consultation. There is wide variation in the number of children prescribed an immediate, delayed, or no antibiotic with regard to parent-reported symptoms and clinical signs.

Relationships between baseline characteristics and health outcomes

Hospitalisation

Table 1 shows the discharge diagnoses for the hospitalised children and whether they received an antibiotic or not. There was no evidence of a difference between hospital diagnoses in children prescribed an antibiotic compared with those who were not (χ2 test: P = 0.46). Table 2 details the univariable and multivariable relationships between antibiotic prescribing at the baseline consultation and subsequent hospitalisation. There was no clear evidence at the univariable level or multivariable level that prescribing immediate or delayed antibiotics reduced the risk of a child being hospitalised in the 30 days post-baseline consultation (immediate RR 0.83, 95% confidence interval [CI] = 0.47 to 1.45; delayed RR 0.70, 95% CI = 0.26 to 1.90, overall P = 0.44).
Table 2.

Association between children’s antibiotic prescription strategies and hospitalisation in the 30 days following the baseline consultation

Not hospitalisedHospitalisedUnivariable analysis clustering by clinicianMultivariable analysis accounting for covariates where P<0.05 and clustering by clinicianAnalysis stratified by propensity score and accounting for clustering by clinician
n%n%RR95% CIP-valueaRR95% CIP-valueaRR95% CIP-valuea
No antibiotic5196/825562.940/6561.5RefRef0.53 (2 df)RefRef0.31 (2 df)bRefRef0.44 (2 df)
Immediate2292/825527.821/6532.31.190. 70 to 1.880.810.40 to 1.320.830.47 to 1.45
Delayed767/82559.34/656.20.680.24 to 1.880.620.22 to 1.660.700.26 to 1.90

Overall P-value.

Covariates included (<0.05): age<(2 years), current asthma, short<(3 days) illness duration prior to baseline, moderate/severe vomiting in the 24 hours before baseline, clinician-reported wheeze, high temperature (age-related cut-offs). df = degrees of freedom. Ref = reference. RR = risk ratio.

Association between children’s antibiotic prescription strategies and hospitalisation in the 30 days following the baseline consultation Overall P-value. Covariates included (<0.05): age<(2 years), current asthma, short<(3 days) illness duration prior to baseline, moderate/severe vomiting in the 24 hours before baseline, clinician-reported wheeze, high temperature (age-related cut-offs). df = degrees of freedom. Ref = reference. RR = risk ratio.

Reconsultation within 30 days for deterioration

Table 3 describes the univariable and multivariable relationships between prescription at the baseline consultation and reconsultation for deterioration. Both univariable and multivariable analysis, accounting for clinician clustering, indicate there is evidence to suggest a difference in those reconsulting with deteriorating symptoms in the subsequent 30 days, for those prescribed an antibiotic compared with those who were not (immediate risk ratio [RR] 0.82, CI = 0.65 to 1.07; delayed RR 0.55, CI = 0.34 to 0.88, overall P = 0.02). Delayed antibiotics reduced reconsultation with deterioration by almost half and, although the point estimate for those prescribed immediate antibiotics suggests a reduction, the 95% CI means the absence of an effect cannot be ruled out.
Table 3.

Association between children’s antibiotic prescription strategies and reconsulting for the same RTI illness with evidence of deterioration in the 30 days following the baseline consultation

No reconsultationReconsulted for deteriorationUnivariable analysis clustering by clinicianMultivariable analysis accounting for where P<0.05 and clustering by clinicianAnalysis stratified by propensity score and accounting for clustering by clinician
n%n%RR95% CIP-valueaRR95% CIP-valueaRR95% CIP-valuea
No antibiotic4864/778662.5240/35068.6RefRef0.008 (2 df)RefRef0.007 (2 df)bRefRef0.024 (2 d.f)
Immediate2175/778627.991/35026.00.850.67 to 1.090.780.61 to 0.990.820.65 to 1.07
Delayed747/77869.619/3505.40.520.32 to 0.870.560.34 to 0.910.550.34 to 0.88

Overall P-value.

Covariates included (P<0.05): moderate/severe vomiting in the 24 hours before baseline, white ethnicity, age<(2 years), short< (3 days) illness duration prior to baseline, clinician-reported wheeze, parent-reported disturbed sleep in the previous 24 hours, moderate or severe vomiting and severe blocked nose in the previous 24 hours. df = degrees of freedom. Ref = reference. RR = risk ratio.

Association between children’s antibiotic prescription strategies and reconsulting for the same RTI illness with evidence of deterioration in the 30 days following the baseline consultation Overall P-value. Covariates included (P<0.05): moderate/severe vomiting in the 24 hours before baseline, white ethnicity, age<(2 years), short< (3 days) illness duration prior to baseline, clinician-reported wheeze, parent-reported disturbed sleep in the previous 24 hours, moderate or severe vomiting and severe blocked nose in the previous 24 hours. df = degrees of freedom. Ref = reference. RR = risk ratio.

DISCUSSION

Summary

This is the first cohort evidence available to date to indicate that prescribing immediate or delayed antibiotics in children does not prevent RTI-related hospitalisation in the 30 days post primary care consultation. Hospital admissions in the 30 days after the baseline consultation were rare and almost none of the reasons for admission were related to the withholding of antibiotics. This has demonstrated that delayed antibiotics reduced the risk of the child reconsulting for the same illness with deterioration. For those given immediate antibiotics, the trend was in the same direction, although no clear evidence was found; it is not clear if this is due to a lack of power or a true finding. This supports previous research in adults that also suggests delayed prescribing should be considered if an antibiotic is being prescribed.

Strengths and limitations

The study’s large observational dataset reflects a realistic primary care setting and the findings are likely to be generalisable to general practice in other high-income countries. Follow-up and case ascertainment were high. The study has several potential limitations. First, prescribing rates were relatively low in this cohort, particularly delayed prescribing, which may impact on the generalisability. The low prescribing rates are likely to be because clinicians who self-classified themselves as ‘low prescribers’ were eligible to recruit to the study. Second, establishing whether prescribed antibiotics were dispensed and consumed was not possible, although previous studies suggest that immediate prescriptions commonly are consumed.31 Third, both health outcomes were rare and event rates low (as expected), particularly hospitalisation, which unavoidably limits analytic power. Fourth, as with any secondary analysis of observational data there may be residual confounding, although only a few variables predicted hospitalisation, which lessens any effect of confounding by indication. For reconsulting for deterioration, very little change in risk ratios were recorded when a wide range of potential covariates were included in the model, which suggests that confounding, for those variables that were recorded, was not a major issue.

Comparison with existing literature

The authors did not find evidence to support the use of an immediate antibiotic prescription as a means of clearly reducing hospitalisations for RTIs. Even if the lower confidence intervals for the estimate are taken, more than 200 children would need to be given an immediate antibiotic for one hospitalisation to be prevented. These findings are in agreement with evidence from systematic reviews11–13,32 where little or no evidence was found to support their use in children or adults. The authors found similar estimates for reconsultations for deterioration with that of one large cohort study investigating new or non-resolving symptoms in adult sore throat.18,19 Similarly, this evidence supports the idea that a delayed antibiotic script is not necessarily equivalent to a ‘no prescription’ strategy and can be a useful means to reduce reconsultations18,19,33,34 as well as the use of antibiotics.31,33–36 Evidence from this cohort demonstrated which symptoms and signs predict complications in children presenting to general practice with acute cough and RTI.5 This may reduce uncertainty around distinguishing which children might benefit from antibiotics, from those who are at a much lower risk of poor health outcomes where the clinician can safely make a ‘no prescription’ decision.21 However, a multifaceted approach and more complex behavioural interventions may be required to support clinicians to reduce their prescribing to children.37–39 Qualitative evidence suggests that the relationship between parents and clinicians, in relation to antibiotic prescribing for their child’s RTI, is complex. Studies show that clinicians are prescribing ‘just in case’,6 feel uncertain about prognostic outcomes,7 and perceive pressure from parents to prescribe when parents want symptomatic relief and safety-netting advice.40,41 The authors’ evidence indicates a delayed prescription reduces the likelihood of a parent reconsulting with their child with deterioration. The reasons for this are not entirely clear, but may represent the timely access to antibiotics if illness is not settling, or prompt treatment of a secondary bacterial infection following an initial viral infection.

Implications for practice

These findings suggest that there is little evidence that antibiotics substantially reduce the risk of hospitalisation in children presenting to primary care; and that these risks are extremely low for the majority of children presenting with acute cough and RTI. The rates of prescribing in this cohort, even for self-classified ‘low prescribers’, indicate continued need for interventions and strategies to better target antibiotics. These results provide reassurance that, when faced with a child and uncertain prognosis, delayed prescribing can be a safe and effective method to reduce the child’s probability of reconsulting with deterioration and can act as part of safety-netting strategies for parents. The implications for clinical practice are that the majority of children presenting with acute cough and respiratory symptoms in primary care are not at risk of hospitalisation, and antibiotics may not reduce the risk. If clinicians are considering an antibiotic, a delayed prescription may be preferable as it is likely to reduce reconsultation for deterioration.
CharacteristicData source
Sociodemographic variables
Age<2 years versus ≥2 yearsParent
SexMale versus femaleParent
Age of mother at child’s birth≤26 years versus >26 yearsParent
Breastfed for ≥3 monthsYes versus noParent
Mother smokesYes versus noParent
Children in the home≥2 versus <2Parent
IMD scoreHigh, top quintile versus quintiles 1 to 4Parent
EthnicityWhite versus mixed, Asian or Asian British, black or black British, Chinese, or other ethnic groupsParent
Past medical history
Consultations for RTI in the 12 months prior to baseline≥2 versus <2General practice medical notes
Asthma (current diagnosis)Yes versus NoGeneral practice medical notes
Chronic conditions (any)Yes versus NoGeneral practice medical notes
Asthma (previous diagnosis)Yes versus NoGeneral practice medical notes
Parent-reported symptoms (present during the illness)
Illness duration prior to baseline (days)<3 versus 3Parent
Breathing faster than normalPresent versus absentParent
High parent illness severity score≥7 versus<7Parent
Low energy/fatigue/lethargyPresent versus absentParent
FeverPresent versus absentParent
Eating lessPresent versus absentParent
Illness much worse recentlyYes versus noParent
Disturbed sleepPresent versus absentParent
Wheezing or whistling in the chestPresent versus absentParent
Chills/shiveringPresent versus absentParent
Taken fewer fluids/milk feedsPresent versus absentParent
Productive wet coughPresent versus absentParent
Vomiting (including after a cough)Present versus absentParent
Passing urine less often/drier nappiesPresent versus absentParent
Change in cryPresent versus absentParent
Dry coughPresent versus absentParent
DiarrhoeaPresent versus absentParent
Barking/croupy coughPresent versus absentParent
Blocked/runny nosePresent versus absentParent
Parent-reported symptoms (last 24 hours)
Change in cry (moderate/severe)Present versus absentParent
Vomiting (moderate/severe)Present versus absentParent
Disturbed sleep (severe)Present versus absentParent
Taking fewer fluids/milk feeds (moderate/severe)Present versus absentParent
Passing urine less often/drier nappies (moderate/severe)Present versus absentParent
Productive wet cough (severe)Present versus absentParent
Chills/shivering (moderate/severe)Present versus absentParent
Eating less (severe)Present versus absentParent
Low energy/fatigue/lethargy (moderate/severe)Present versus absentParent
Wheeze (moderate/severe)Present versus absentParent
Fever (severe)Present versus absentParent
Breathing faster than normal (moderate/severe)Present versus absentParent
Blocked/runny nose (severe)Present versus absentParent
Dry cough (severe)Present versus absentParent
Barking/croupy cough (moderate/severe)Present versus absentParent
Diarrhoea (moderate/severe)Present versus absentParent
Clinical signs
Inter/subcostal recessionPresent versus absentClinician
Bronchial breathing (unilateral/bilateral)Present versus absentClinician
Nasal flaringPresent versus absentClinician
PallorPresent versus absentClinician
Wheeze (unilateral/bilateral)Present versus absentClinician
Abnormal consciousnessYes versus noClinician
High temperature≥37.8°C versus <37.8°CClinician
High respiratory rate (age-related cut-offs)Present versus absentClinician
High pulse (age-related cut-offs)Present versus absentClinician
Inflamed pharynxPresent versus absentClinician
GruntingPresent versus absentClinician
Crackles/crepitations (unilateral/bilateral)Present versus absentClinician
Slow capillary refill time≥3 seconds versus ≤2 secondsClinician
StridorPresent versus absentClinician
High clinician illness severity score≥4 versus <4Clinician
Clinician gut feeling that ‘something is wrong’Yes versus noClinician

IMD = Index of Multiple Deprivation. RTI = respiratory tract infection.

No antibioticImmediate antibioticsDelayed antibiotics
n/N%n/N%n/N%
Clinical history
RTI consultations in the 12 months prior to baseline (≥2 consultations)1739/510634839/226937262/76634
Any chronic conditiona916/523518492/231121157/77120
Current asthma diagnosisb415/52368247/23131177/77110
Previous asthma diagnosis184/52354124/2313541/7715
Sociodemographics
Sex (male)2693/5236511230/231353365/77147
Age (<2 years)1875/523636715/231331212/77128
Children in the home (>1)3292/5213631644/230371526/76569
Breastfeeding (at 3 months)2132/488744934/211744350/71849
Ethnicity (white)4015/5212771889/229882585/76676
Mother smokes914/517818447/227720115/75915
Young mother1566/522230652/230428197/76826
IMD quintile (most deprived)1066/523620436/231319117/77115
Parent-reported symptoms present at any time during the illness
High severity score (parent: ≥7/10)993/521819914/230540209/77127
Short duration of illness (≤3 days)1598/523331533/231223234/77130
Illness worsened recently3114/5230601835/231079527/77068
Dry cough3326/5234641205/230952447/77158
Productive wet cough2556/5230491455/231063440/77057
Barking/croupy cough1357/523226605/230726161/77121
Blocked/runny nose4202/5234801833/231179620/77081
Change in cry850/522116385/230217131/76617
Breathing quicklyc1602/5235311057/231146279/77136
Wheezing/whistling in chest1885/5232361058/231146303/77139
Chills948/523318679/231029212/77028
Fever2865/5234551733/231175533/77169
Diarrhoea783/523315340/231115101/77113
Vomitingd1349/523426765/231133201/77126
Eating less than normal2855/5232551627/231070498/77165
Fewer fluids1529/523229834/230936253/77133
Low energy2512/5234481475/231064483/77163
Disturbed sleep3880/5234741926/231183592/77077
Less urine than normal652/522313348/230715131/77017
Parent-reported symptoms present in the last 24 hours (severe)
Dry cough337/52156174/2306840/7685
Productive wet cough329/52156270/23041268/7709
Blocked/runny nose406/52028201/2304952/7657
Fever228/52174236/23021070/7689
Eating less208/52134175/2299838/7695
Disturbed sleep784/520815430/230519116/76515
Parent-reported symptoms present in the last 24 hours (moderate or severe)
Barking cough957/522618446/230319111/77114
Change in cry480/52129224/23011073/76510
Chills/shivering382/52297362/23051684/76911
Breathing quicklyc836/522416619/230827146/77119
Wheeze878/522517585/230525128/77117
Diarrhoea216/52294103/2309522/7713
Vomitingd460/52279290/23101374/77010
Taking fewer fluids/milk feeds641/522412388/230217107/76914
Low energy/fatigue/lethargy1192/521323824/230136229/76830
Passing urine less often256/52135158/2306742/7696
Physical examination signs
Pallor284/52275439/23111984/77111
Nasal flaring39/5228151/231126/7711
Grunting25/5227040/231026/7711
Inter/subcostal recession131/52273226/23101021/7713
Wheeze498/522810624/23082787/77111
Crackles/crepitations128/522721300/231056130/77017
Bronchial breathing43/52251210/2307921/7693
Inflamed pharynx1250/521224828/230836299/77139
Stridor25/5226011/231005/7711
Abnormal consciousness42/5229173/230837/7681
High respiratory rate619/521212492/230021107/76314
High temperature ≥37.8°Ce346/52237567/230725116/77015
High pulse170/52033178/2297833/7664
Capillary refill rate (≥3 seconds)41/5216118/230416/7631
High severity score (clinician: (≥4/10)1038/5233201502/229665341/76844
Gut feeling something is wrong273/523051265/230755110/76614
Adverse health outcomes in the 30 days post-baseline
Hospitalised40/5236121/231314/7711
Reconsulted general practice for the same RTI illness with evidence of symptom deterioration240/5104591/2266419/7662

Includes both current and previous asthma diagnosis.

Defined as present if asthma in medical notes problem list and asthma medication issued in the previous 12 months.

Faster than normal.

Including after a cough.

High temperature (age-related cut-offs). IMD = Index of Multiple Deprivation. RTI = respiratory tract infection.

  35 in total

Review 1.  Antibiotics for bronchiolitis in children.

Authors:  Geoffrey Kp Spurling; Jenny Doust; Chris B Del Mar; Lars Eriksson
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

2.  Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial.

Authors:  Paul Little; Kate Rumsby; Joanne Kelly; Louise Watson; Michael Moore; Gregory Warner; Tom Fahey; Ian Williamson
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

Review 3.  Antibiotics for acute otitis media in children.

Authors:  Roderick P Venekamp; Sharon L Sanders; Paul P Glasziou; Chris B Del Mar; Maroeska M Rovers
Journal:  Cochrane Database Syst Rev       Date:  2015-06-23

4.  The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians.

Authors:  I M Okkes; S K Oskam; H Lamberts
Journal:  J Fam Pract       Date:  2002-01       Impact factor: 0.493

5.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

6.  "They just say everything's a virus"--parent's judgment of the credibility of clinician communication in primary care consultations for respiratory tract infections in children: a qualitative study.

Authors:  Christie Cabral; Jenny Ingram; Alastair D Hay; Jeremy Horwood
Journal:  Patient Educ Couns       Date:  2014-01-30

Review 7.  Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-02-18

8.  Delayed antibiotic prescribing and associated antibiotic consumption in adults with acute cough.

Authors:  Nick A Francis; David Gillespie; Jacqueline Nuttall; Kerenza Hood; Paul Little; Theo Verheij; Herman Goossens; Samuel Coenen; Christopher C Butler
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

Review 9.  A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care.

Authors:  Patricia J Lucas; Christie Cabral; Alastair D Hay; Jeremy Horwood
Journal:  Scand J Prim Health Care       Date:  2015-02-26       Impact factor: 2.581

10.  Primary care clinician antibiotic prescribing decisions in consultations for children with RTIs: a qualitative interview study.

Authors:  Jeremy Horwood; Christie Cabral; Alastair D Hay; Jenny Ingram
Journal:  Br J Gen Pract       Date:  2016-02-07       Impact factor: 5.386

View more
  3 in total

1.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

2.  Quality of life, healthcare use and costs in 'at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: within-trial descriptive economic analyses of the ARCHIE randomised controlled trial.

Authors:  Ines Rombach; Kay Wang; Sharon Tonner; Jenna Grabey; Anthony Harnden; Jane Wolstenholme
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

3.  Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial.

Authors:  Paul Little; Nick A Francis; Beth Stuart; Gilly O'Reilly; Natalie Thompson; Taeko Becque; Alastair D Hay; Kay Wang; Michael Sharland; Anthony Harnden; Guiqing Yao; James Raftery; Shihua Zhu; Joseph Little; Charlotte Hookham; Kate Rowley; Joanne Euden; Kim Harman; Samuel Coenen; Robert C Read; Catherine Woods; Christopher C Butler; Saul N Faust; Geraldine Leydon; Mandy Wan; Kerenza Hood; Jane Whitehurst; Samantha Richards-Hall; Peter Smith; Michael Thomas; Michael Moore; Theo Verheij
Journal:  Lancet       Date:  2021-09-22       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.